EU seeks consistency in South Korea trade deal
This article was originally published in Scrip
The EU is not seeking to change its policy or rules on pharmaceutical patent linkage as part of its free trade agreement (FTA) discussions with South Korea. But any deal should be consistent with the trade pact already agreed between the Asian country and the US.
You may also be interested in...
Partners say they are encouraged by new overall response data from early trials for the two drugs together in kidney and liver cancer, presented to ASCO.
Focused on precision medicine for renal disease, Chinook gets Aduro’s Nasdaq listing and starting capital of $200m. During a wave of modest-sized M&A deals, Tetra finds buyer, Tetraphase gets competing bids.
Takeda is confident about the promise of its first-in-class molecule for higher-risk myelodysplastic syndromes after positive Phase II data.